Pregnancy-induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type 1 diabetes

Growth Hormone and IGF Research

Volumn 21, Issue 1, 2011, Pages 25-30

  Ringholm, Lene ^a   Vestgaard, Marianne ^a   Laugesen, Caroline S ^a,b   Juul, Anders ^a,c   Damm, Peter ^a,c   Mathiesen, Elisabeth R ^a,c  

^a Rigshospitalet   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diabetic retinopathy; Growth hormone; IGF I; Pregnancy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HORMONE; INSULIN; PLACENTAL GROWTH HORMONE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FIRST TRIMESTER PREGNANCY; GROWTH HORMONE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PREGNANCY; PREGNANCY IN DIABETICS; PROGNOSIS; UP-REGULATION; YOUNG ADULT;

EID: 79951726104     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.12.001     Document Type: Article

References (29)

1. Dibble C.M., Kochenour N.K., Worley R.J., Tyler F.H., Swartz M. Effect of pregnancy on diabetic retinopathy. Obstet. Gynecol. 1982, 59:699-704.
2. Moloney J.B., Drury M.I. The effect of pregnancy on the natural course of diabetic retinopathy. Am. J. Ophthalmol. 1982, 93:745-756.
3. Soubrane G., Canivet J., Coscas G. Influence of pregnancy on the evolution of background retinopathy. Preliminary results of a prospective fluorescein angiography study. Int. Ophthalmol. 1985, 8:249-255.
4. Temple R.C., Aldridge V.A., Sampson M.J., Greenwood R.H., Heyburn P.J., Glenn A. Impact of pregnancy on the progression of diabetic retinopathy in Type 1 diabetes. Diabet. Med. 2001, 18:573-577.
5. Vestgaard M., Ringholm L., Laugesen C.S., Rasmussen K.L., Damm P., Mathiesen E.R. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes. Diabet. Med. 2010, 27:431-435.
6. Frystyk J. The growth hormone hypothesis - 2005 revision. Horm. Metab. Res. 2005, 37(Suppl 1):44-48.
7. Lundbaek K., Christensen N.J., Jensen V.A., et al. Diabetes, diabetic angiopathy, and growth hormone. Lancet 1970, 2:131-133.
8. Chellakooty M., Vangsgaard K., Larsen T., et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J. Clin. Endocrinol. Metab. 2004, 89:384-391.
9. Fuglsang J., Lauszus F., Flyvbjerg A., Ovesen P. Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:4355-4361.
10. Eriksson L., Frankenne F., Eden S., Hennen G., von Schoultz B. Growth hormone 24-h serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br. J. Obstet. Gynaecol. 1989, 96:949-953.
11. Lauszus F.F., Klebe J.G., Bek T., Flyvbjerg A. Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes 2003, 52:852-856.
12. Nielsen L.R., Damm P., Mathiesen E.R. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?. Diab. Care 2009, 32:38-44.
13. Klein R., Klein B.E., Moss S.E. Visual impairment in diabetes. Ophthalmology 1984, 91:1-9.
14. Wilkinson C.P., Ferris F.L., Klein R.E., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.
15. Igout A., van Beeumen J., Frankenne F., Scippo M.L., Devreese B., Hennen G. Purification and biochemical characterization of recombinant human placental growth hormone produced in Escherichia coli. Biochem. J. 1993, 295(Pt 3):719-724.
16. Nielsen L.R., Ekbom P., Damm P., et al. HbA1c levels are significantly lower in early and late pregnancy. Diab. Care 2004, 27:1200-1201.
17. Nielsen L.R., Pedersen-Bjergaard U., Thorsteinsson B., Johansen M., Damm P., Mathiesen E.R. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diab. Care 2008, 31:9-14.
18. Vestgaard M., Nielsen L.R., Rasmussen A.K., Damm P., Mathiesen E.R. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome. Acta Obstet. Gynecol. Scand. 2008, 87:1336-1342.
19. Marsal K., Persson P.H., Larsen T., Lilja H., Selbing A., Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996, 85:843-848.
20. Merimee T.J., Zapf J., Froesch E.R. Insulin-like growth factors. Studies in diabetics with and without retinopathy. N. Engl. J. Med. 1983, 309:527-530.
21. Thrailkill K.M., Quattrin T., Baker L., Kuntze J.E., Compton P.G., Martha P.M. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diab. Care 1999, 22:585-592.
22. Smith L.E., Shen W., Perruzzi C., et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 1999, 5:1390-1395.
23. Grant M., Russell B., Fitzgerald C., Merimee T.J. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 1986, 35:416-420.
24. Ringholm N.L., Juul A., Pedersen-Bjergaard U., Thorsteinsson B., Damm P., Mathiesen E.R. Lower levels of circulating IGF-I in Type 1 diabetic women with frequent severe hypoglycaemia during pregnancy. Diabet. Med. 2008, 25:826-833.
25. Chew E.Y., Mills J.L., Metzger B.E., et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diab. Care 1995, 18:631-637.
26. Nielsen L.R., Muller C., Damm P., Mathiesen E.R. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria-possible effect of early antihypertensive treatment during pregnancy. Diabet. Med. 2006, 23:426-431.
27. Gibson J.M., Aplin J.D., White A., Westwood M. Regulation of IGF bioavailability in pregnancy. Mol. Hum. Reprod. 2001, 7:79-87.
28. Langford K.S., Nicolaides K.H., Jones J., Abbas A., McGregor A.M., Miell J.P. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J. Clin. Endocrinol. Metab. 1995, 80:21-27.
29. Attia N., Caprio S., Jones T.W., et al. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 1999, 84:2324-2328.